Follicular hyperplasia Acetylcholine receptor antibodies Acides nucléiques endogènes MYB Immunity Autoimmunity Cytokines Glucocorticoids Genetic associations Gender CD31 COVID-19 Max Inflammatory cytokines Interferon Interleukin 23 COX2 Thymoma Genetics Gd T cells Immunotherapy Interferonopathy Neuromuscular junction Myoblasts Ferrites Cellules th17 Immune response Interferon-β LMNA M3243AG DICER Experimental models Mass cytometry CyTOF FMR1 Human myoblasts Fragile X syndromes Ectopic germinal centers Heart failure Thymus Experimental autoimmune myasthenia gravis Chronicity MG patients Early-onset myasthenia gravis Il-23 Immune regulation Myasthénie grave Auto-immunité CCL21 PBMC Myasthenia Gravis MG Complete Freund's adjuvant Macrophages Innate immunity Chronic inflammation Myasthenia gravis Transcriptome Acetylcholine receptor Interferon type I Centres germinatifs ectopiques Autoimmune disease Lamin A/C nuclei Clinical cell transplantation Adaptive immunity Autoimmune diseases Etiology Endogenous nucleic acids Quality of life AChR antibodies Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Conduction disease Interleukine-23 Acetylcholine receptors Experimental autoimmune myasthenia gravis EAMG CTCF BAFF B cells Animal models Antimir-150 Interferon de type I Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Interféron de type I Disease susceptibility Chemokine Long-term follow-up CXCL13-CXCR5 Interferon type-I Inflammation Maladie auto-immune Chemokines Exercise Anticorps monoclonal Age Th17 cells Germinal centers Immunology and Microbiology Section Cardiomyopathy Germinal center Thymic epithelial cells Interferon IFN Experimental mouse models